CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Guy'S and St. Thomas Hospital
London, United Kingdom
- St. Bartholomew'S Hospital
London, United Kingdom
- Grandview Medical Center
Birmingham, Alabama, United States
- Heart Center Research Llc
Huntsville, Alabama, United States
- Rose Medical Center / Medical Center of Aurora
Denver, Colorado, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- St. Vincent'S Healthcare
Jacksonville, Florida, United States
- Mt Sinai Medical Center
Miami Beach, Florida, United States
- Palm Beach Gardens Medical Center
Palm Beach Gardens, Florida, United States
- Emory University - St. Joseph'S Hospital
Atlanta, Georgia, United States
- St. Vincent Medical Group Inc.
Indianapolis, Indiana, United States
- Cardiovascular Research Foundation of Louisiana
Baton Rouge, Louisiana, United States
- Lahey Clinic
Burlington, Massachusetts, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- Cardiology Associates Research, Llc
Tupelo, Mississippi, United States
- Maimonides Medical Center
Brooklyn, New York, United States
- Staten Island University Hospital
Staten Island, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- East Carolina University - Vidant Medical Center
Greenville, North Carolina, United States
- Wake Medical Center / Cary Research Group
Raleigh, North Carolina, United States
- Summa Health System
Akron, Ohio, United States
- Riverside Hospital / Ohiohealth
Columbus, Ohio, United States
- Upmc Pinnacle Hospitals
Harrisburg, Pennsylvania, United States
- Allegheny-Singer Research Institute
Pittsburgh, Pennsylvania, United States
- Austin Heart Pllc
Austin, Texas, United States
- Star Clinical Trials Llc
San Antonio, Texas, United States
- Virginia Cardiovascular Specialists
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 31 Aug 2019
- Completion
- 31 Oct 2023
- Last update posted
- 13 Nov 2023
- Registered enrollment
- 170
- Registry id
- NCT01984346
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.